Health Share Gains Big After a Strong Quarter

The stock of P3 Health Partners shot up more than 42% in after‑hours trading, a sharp change from the fourth quarter where earnings per share were a loss of $23. 02, far below analyst expectations. This bounce comes after the company posted a 4% increase in revenue to $386 million, and a notable jump of 14% in per‑member revenue thanks to new contract terms and higher rates. Adjusted EBITDA reached $25. 8 million, which works out to about $81 for each member per month. Net profit turned positive at $3 million, a reversal from the $44. 2 million loss recorded in the same period last year. CEO Dr. Aric Coffman said that two years of focused effort on restructuring contracts, narrowing the network, and redesigning operations have paid off. Because of this progress, the firm has raised its full‑year 2026 adjusted EBITDA target to a midpoint of $40 million.The company also provided guidance for total revenues between $1. 50 billion and $1. 65 billion, and adjusted EBITDA ranging from $20 million to $60 million for the year. The company’s market cap sits at about $29 million. Over the past twelve months, its share price has fallen by more than half, trading near the lower end of its 52‑week range. Technical indicators show a Relative Strength Index of roughly 72, suggesting the stock is in an overbought zone. During regular trading hours, P3 Health closed up nearly 13%, and analysis from Benzinga indicates a pattern of long‑term consolidation with short‑term gains.